Ascentage Pharma

US · AAPG #3045 by market cap Listed 2025

14.94 -1.15 -7.15%

Live - 5344 symbols - heartbeat 362s ago · 2026-10-08 05:05

Pre-market 14.71 -1.54%

After-hours 14.94 0.00%

Overnight 14.70 -1.61%

Market cap: 1.40B
P/E (TTM): -6.37
P/B: 16.81
EPS: -1.99
Div yield: 0.00%
52W pos: 2%

Reader sentiment Are you bullish or bearish on AAPG?

Anonymous reader poll. Unscientific, not investment advice.

About Ascentage Pharma

Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.

Founded: 2009
CEO: Dr. Dajun Yang, M.D.,PhD
Employees: 767
Headquarters: Suzhou, Jiangsu, China
Fiscal year end: 12-31
Website: ascentage.com

Company profile

Exchange: US
Symbol: AAPG
Market-cap rank: #3045
Listing date: 2025-01-24
Market cap: 1.40B
Float cap: 1.07B
Shares out: 93.39M
Float shares: 71.93M

Sectors & themes

Biotechnology HK ADR Fractional Shares JP Chinese Concept

Browse all sectors & themes

Quote time 2026-10-08 05:05:11 · For reference only, not investment advice and not tailored to your situation.